Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Derma
Exclusive Distributor Agreement with Symatese Broadens Evolus’ Dermal Filler Footprint Beyond the U.S. to Include the United Kingdom and EuropeEuropean Regulatory Approvals Anticipated in Second Half of 2024Company Continues to Expect to be Fully Funded to Profitability1NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus...
Source: pharmiweb.com